accountreaction, low white blood cells LOS ANGELES, May 18 (Reuters) - Nexavar, the cancer drug sold by Onyx Pharmaceuticals Inc (ONXX.O Nexavar is already approved to treat kidney and liver tumors in Europe, Asia and North America. Analysts, on average, have...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Onyx's Nexavar shown to help breast cancer patients
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account